[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-334379-105":59,"doc-detail-334379-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","mir-214-3p-overexpression-triggered-chondroitin-polymerizing-factor-chpf-inhibition-modulates-the-ferroptosis-and-metabolism-in-colon-cancer","MiR-214-3p overexpression-triggered chondroitin polymerizing factor (CHPF) inhibition modulates the ferroptosis and metabolism in colon cancer","","Colon cancer is common worldwide and carries high mortality. The study investigates chondroitin polymerizing factor (CHPF), which has been linked to multiple cancers, yet remains unclear in colon cancer. CHPF expression and its association with miR-214-3p are measured using GEPIA database, RT-qPCR, and western blot, alongside analysis of clinicopathologic features and patient outcomes. Cell and animal experiments evaluate how CHPF affects tumor growth, ferroptosis, and glycolysis. CHPF is elevated in colon cancer and correlates with advanced TNM stage, poor differentiation, and shorter overall survival. CHPF knockdown suppresses growth and lowers ferroptosis- and glycolysis-related proteins. Mechanistically, miR-214-3p directly targets CHPF: miR-214-3p upregulation reduces viability and glycolytic outputs while increasing ferrous iron and ROS, effects reversed by CHPF overexpression. The miR-214-3p/CHPF axis therefore inhibits growth, decreases glycolysis indexes, and promotes ferroptosis, with CHPF upregulation predicting poor prognosis.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/mir-214-3p-overexpression-triggered-chondroitin-polymerizing-factor-chpf-inhibition-modulates-the-ferroptosis-and-metabolism-in-colon-cancer/334379/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/mir-214-3p-overexpression-triggered-chondroitin-polymerizing-factor-chpf-inhibition-modulates-the-ferroptosis-and-metabolism-in-colon-cancer/334379.png","ImageObject",300,407,{"name":92,"@type":93},"Valentina","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main purpose of the study regarding CHPF in colon cancer?","Question",{"text":112,"@type":113},"To determine the role and underlying mechanism of chondroitin polymerizing factor (CHPF) in colon cancer, especially its relationship with miR-214-3p, ferroptosis, and metabolism.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was CHPF expression evaluated and linked to clinical features?",{"text":117,"@type":113},"CHPF expression was assessed using GEPIA database together with RT-qPCR and western blot, then correlated with clinicopathologic characteristics, miR-214-3p levels, and patient prognosis.",{"name":119,"@type":110,"acceptedAnswer":120},"What effect does miR-214-3p have on colon cancer cells through CHPF?",{"text":121,"@type":113},"miR-214-3p directly targets CHPF and negatively regulates its expression; increasing miR-214-3p reduces viability, glucose uptake, lactate production, and ATP levels while increasing ferrous iron and ROS, and these effects are reversed by CHPF overexpression.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},334379,1790189204,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":4},13056703020460,"https://ap-avatar.wpscdn.com/avatar/be000253dac470eee5d?_k=1778207105932848923","DOI: 10.1002/kjm2.12802  \nO R IG INA L ARTI CLE  \nMiR-214-3p overexpression-triggered chondroitin polymerizing factor (CHPF) inhibition modulates the ferroptosis and metabolism in colon cancer  \nZhi-Yuan Yun 1 | Di Wu 2 | Xin Wang 1 | Peng Huang 3 | Na Li 1   \n1Department of Internal Medicine, Harbin Medical University Cancer Hospital, Harbin Medical University, Harbin, Heilongjiang, China  \n2Department of Colorectal Surgery, Harbin Medical University Cancer Hospital, Harbin Medical University, Harbin, Heilongjiang, China  \n3Department of Gastrointestinal Oncology, Harbin Medical University Cancer Hospital, Harbin Medical University, Harbin, Heilongjiang, China  \nCorrespondence  \nNa Li, Department of Internal Medicine, Harbin Medical University Cancer Hospital, Harbin Medical University, No. 150, Haping Road, Harbin, Heilongjiang, 150081, China.  \nEmail: [linahmuchdoc@21cn.com](linahmuchdoc@21cn.com)  \nAbstract  \nColon cancer is a common cancer with high mortality globally. The role of chondroitin polymerizing factor (CHPF) has been elucidated in various cancers. However, its role and mechanism remain unknown in colon cancer. CHPF expression was examined by GEPIA database, reverse transcription-quantitative polymerase chain reaction and western blot. The relationship between CHPF expression and the clinicopathologic characteristics as well as miR-214-3p level was determined in colon cancer patients. The role and mechanism of CHPF in the growth, ferroptosis, and glycolysis of colon cancer cells were evaluated by cell counting kit-8, biochemical detections, luciferase, and western blot experiments. Additionally, the role of CHPF was explored in xenografted mice. CHPF expression was increased and was related to advanced TNM stage, poor differentiation and shorter overall survival in patients with colon cancer. Knockdown of CHPF inhibited colon cancer cell growth, and downregulated the expression of proteins involving in ferroptosis and glycolysis both in vitro and in vivo. Besides, CHPF silencing increased the levels of ferrous iron and ROS, but decreased glucose uptake, lactate product, and ATP level in vitro. Mechanically, miR-214-3p directly targeted CHPF and negatively regulated its expression. Upregulation of miR- 214-3p reduced cell viability, glucose uptake, lactate product, and ATP level, but increased the levels of ferrous iron and ROS, which were reversed by the overexpression of CHPF. Upregulation of CHPF predicted poor prognosis, and miR-214-3p/ CHPF axis inhibited growth, downregulated the levels of glycolysis-related indexes, and promoted ferroptosis in colon cancer cells.  \nKEYWOR DS  \nchondroitin polymerizing factor, colon cancer, ferroptosis, glycolysis, prognosis  \n1 | INTRODUCTION  \nColon cancer, one of the most common tumors, severely threatens human health. Colon cancer ranks as the second and the third most  \ncommon cancer in women and men worldwide, respectively. It is reported that more than 1 .9 million new colon cancer cases are diagnosed and 0 .9 million deaths are occurred in 2020 .1 Multiple approaches can be used for the treatment of colon cancer based on  \nThis is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.  \n© 2024 The Authors. The Kaohsiung Journal of Medical Sciences published by John Wiley & Sons Australia, Ltd on behalf of Kaohsiung Medical University.  \ntumor stage. More than four-fifths of patients with colon cancer at stage I and II receive colectomy, while about two-thirds of patients at stage III undergo adjuvant chemotherapy.2 As for patients at stage IV, approximately one-half accept surgical therapy, generally accompanied by radiotherapy and/or chemotherapy.2 Nevertheless, chemotherapy and radiotherapy usually result in a variety of side effects and resistance","cbCaigEaNLla2XPB","https://ap.wps.com/l/cbCaigEaNLla2XPB","pdf",3296801,11,"English","# Abstract\n# Introduction\n## Overview of colon cancer and unmet clinical needs\n## Role of CHPF in cancer biology\n# Materials and Methods\n## CHPF and miR-214-3p expression assessment\n## Functional assays for ferroptosis and glycolysis\n## Xenograft experiments","[{\"question\":\"What is the main purpose of the study regarding CHPF in colon cancer?\",\"answer\":\"To determine the role and underlying mechanism of chondroitin polymerizing factor (CHPF) in colon cancer, especially its relationship with miR-214-3p, ferroptosis, and metabolism.\"},{\"question\":\"How was CHPF expression evaluated and linked to clinical features?\",\"answer\":\"CHPF expression was assessed using GEPIA database together with RT-qPCR and western blot, then correlated with clinicopathologic characteristics, miR-214-3p levels, and patient prognosis.\"},{\"question\":\"What effect does miR-214-3p have on colon cancer cells through CHPF?\",\"answer\":\"miR-214-3p directly targets CHPF and negatively regulates its expression; increasing miR-214-3p reduces viability, glucose uptake, lactate production, and ATP levels while increasing ferrous iron and ROS, and these effects are reversed by CHPF overexpression.\"}]","MiR-214-3p overexpression-triggered chondroitin polymerizing factor (CHPF) inhibition modulates the ferroptosis and metabolism in colon cancer | PDF",1790006427,28]